The Patient Safety Movement Pledge to Improve Prevention of Severe Hypoglycemia: Part 3
In part 2 of this series dedicated to the Patient Safety Movement Pledge, we educated our readers on the performance gap and explained that hospitals and healthcare systems will have to take action in specific leadership, practice, and technology plans in order to predict and prevent severe hypoglycemia episodes. Below are the suggested plans.
Leadership Plan
- Must include the fundamentals of change outlined in the National Quality Forum Safe Practices
- Hospital governance must understand the performance gaps in their own healthcare system and must close these gaps with a comprehensive approach
- Hospitals should set a goal date including measurable quality indicators and milestones
- The hospital’s budget for the plan needs to be evaluated by the governance boards
- The plan needs to be endorsed by clinical and safety leadership
Practice Plan
- Create a multidisciplinary team dedicated to glycemic management and best practices
- Develop a systematic approach to reducing severe hypoglycemia by identifying events and prioritizing them in order to raise institutional awareness and educate the hospital staff
- Implement Foundational Best Practices and “Just Do Its”
- Investigate glycemic events and collect causative factors such as insulin stacking and insufficient glycose monitoring
- Share strategies and implement informed interventions on target floors and patients.
Technology Plan
- Implement for insulin therapy recommendation
- Implement real-time surveillance method for informatics alerts
- Implement an automated hypoglycemia event analysis tool
- Implement point-of-care blood glucose monitoring and reporting systems to include quality insurance reports
- Implement automated triggers for most common causative factors of hypoglycemia
- Implement a results dashboard for each nursing unit within the hospital to resolve hypoglycemic events
- Set restrictions for prescribing insulin to only specialists
Related posts

News
Monarch Medical Technologies Joins Glooko to Advance Connected Diabetes Care
Monarch Medical Technologies Joins Glooko to Advance Connected Diabetes Care
We are excited to announce that Monarch Medical Technologies, the creator of EndoTool® Glucose Management System, has been acquired by Glooko, a global leader in diabetes management solutions. For EndoTool customers, nothing changes in the care and support you receive. ...

Blog
5 Tips to Build a Winning Business Case for Patient-Specific Insulin Dosing Software
5 Tips to Build a Winning Business Case for Patient-Specific Insulin Dosing Software
When clinicians ask me, "How do we move beyond standard insulin protocols and implement a glycemic management software solution without getting stuck in committee?" My answer is simple: pair clinical impact with financial clarity. Below are five practical tips I've ...

Blog
Monarch Medical Technologies Named Among TIME’s World’s Top HealthTech Companies 2025
Monarch Medical Technologies Named Among TIME’s World’s Top HealthTech Companies 2025
Innovation in patient-specific insulin dosing just earned global recognition as Monarch Medical Technologies has been recognized by TIME and Statista on their list of the World's Top HealthTech Companies 2025. This recognition underscores the impact of our mission: creating a ...
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields